Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Daniel Mekonnen, Hylemariam Mihiretie Mengist & Tengchuan Jin. (2022) SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways. Expert Review of Vaccines 21:1, pages 69-81.
Read now
Read now
Sara Ayazian Mavi, Mohammad Hossein Modarressi, Mehdi Mohebali, Saeedeh Shojaee, Hojjat Zeraati, Aref Teimouri & Hossein Keshavarz. (2019) Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice. Infection and Drug Resistance 12, pages 2519-2530.
Read now
Read now
Mohamed A. Farrag, Haitham M. Amer, Peter Öhlschläger, Maaweya E. Hamad & Fahad N. Almajhdi. (2017) Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency. Human Vaccines & Immunotherapeutics 13:7, pages 1586-1597.
Read now
Read now
Abid H. Banday, Salika Jeelani & Victor J. Hruby. (2015) Cancer vaccine adjuvants – recent clinical progress and future perspectives. Immunopharmacology and Immunotoxicology 37:1, pages 1-11.
Read now
Read now
Benjamin Yang, Jessica Jeang, Andrew Yang, T C Wu & Chien-Fu Hung. (2014) DNA vaccine for cancer immunotherapy. Human Vaccines & Immunotherapeutics 10:11, pages 3153-3164.
Read now
Read now
Christian Bode, Gan Zhao, Folkert Steinhagen, Takeshi Kinjo & Dennis M Klinman. (2011) CpG DNA as a vaccine adjuvant. Expert Review of Vaccines 10:4, pages 499-511.
Read now
Read now
Carla Herberts, Barbro Melgert, Jan Willem van der Laan & Marijke Faas. (2010) New adjuvanted vaccines in pregnancy: what is known about their safety?. Expert Review of Vaccines 9:12, pages 1411-1422.
Read now
Read now
Sheeba Alam & Douglas G McNeel. (2010) DNA vaccines for the treatment of prostate cancer. Expert Review of Vaccines 9:7, pages 731-745.
Read now
Read now
Manoli Igartua & José Luís Pedraz. (2010) Topical resiquimod: a promising adjuvant for vaccine development?. Expert Review of Vaccines 9:1, pages 23-27.
Read now
Read now
Elżbieta Katarzyna Jagusztyn-Krynicka, Paweł Łaniewski & Agnieszka Wyszyńska. (2009) Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis. Expert Review of Vaccines 8:5, pages 625-645.
Read now
Read now
Steven Dow. (2008) Liposome–nucleic acid immunotherapeutics. Expert Opinion on Drug Delivery 5:1, pages 11-24.
Read now
Read now
Articles from other publishers (103)
Federica Compostella, Laura Morelli & Luigi Lay. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics
1
56
.
Valérie Lannoy, Anthony Côté-Biron, Claude Asselin & Nathalie Rivard. (2023) TIRAP, TRAM, and Toll-Like Receptors: The Untold Story. Mediators of Inflammation 2023, pages 1-13.
Crossref
Crossref
Navya Bellamkonda, Upendra Pradeep Lambe, Sonali Sawant, Shyam Sundar Nandi, Chiranjib Chakraborty & Deepak Shukla. (2022) Immune Response to SARS-CoV-2 Vaccines. Biomedicines 10:7, pages 1464.
Crossref
Crossref
Robert A. Mitchell, Rita Altszuler, Sandra Gonzalez, Roshawn Johnson, Ute Frevert & Elizabeth Nardin. (2022) Innate Immune Responses and P. falciparum CS Repeat-Specific Neutralizing Antibodies Following Vaccination by Skin Scarification. Frontiers in Immunology 13.
Crossref
Crossref
Sabya Sachi Das, Ishan Moitra, Sandeep Kumar Singh, P.R.P. Verma & Suryakanta Swain. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges
259
278
.
Haiyue Xu, Lucy Cai, Stephanie Hufnagel & Zhengrong Cui. (2021) Intranasal vaccine: Factors to consider in research and development. International Journal of Pharmaceutics 609, pages 121180.
Crossref
Crossref
Muhammet Karakavuk, Hüseyin Can, Aytül Gül, Aysu Değirmenci Döşkaya, Sedef Erkunt Alak, Cemal Ün, Adnan Yüksel Gürüz & Mert Döşkaya. (2021) GRA8 DNA vaccine formulations protect against chronic toxoplasmosis. Microbial Pathogenesis 158, pages 105016.
Crossref
Crossref
Niall McMullan. 2021. Molecular Biology and Biotechnology. Molecular Biology and Biotechnology
440
488
.
Atefeh Sadeghi Shermeh, Farnaz Zahedifard, Sima Habibzadeh, Tahereh Taheri, Sima Rafati & Negar Seyed. (2021) Evaluation of protection induced by in vitro maturated BMDCs presenting CD8+ T cell stimulating peptides after a heterologous vaccination regimen in BALB/c model against Leishmania major. Experimental Parasitology 223, pages 108082.
Crossref
Crossref
Masoumeh Khodadadi, Fatemeh Ghaffarifar, Abdolhosein Dalimi & Ehsan Ahmadpour. (2021) Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice. Acta Tropica 216, pages 105836.
Crossref
Crossref
Yang Luo, Xiaoyi Fu, Ruizhen Ru, Bin Han, Fafu Zhang, Lihong Yuan, Hongsheng Men, Shulin Zhang, Sujuan Tian, Bin Dong & Minjie Meng. (2020) CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis. Archives of Medical Research 51:3, pages 233-244.
Crossref
Crossref
Anil Pushpakumara, Chatchote Thitaram & Janine L. Brown. 2019. Veterinary Reproduction and Obstetrics. Veterinary Reproduction and Obstetrics
724
744
.
María Cristina Pistoresi-Palencia, María Florencia Harman & Sofía Daiana Castell. 2019. Handbook of Immunosenescence. Handbook of Immunosenescence
711
731
.
Anna-Mari Reid & Namrita Lall. 2019. Medicinal Plants. Medicinal Plants
187
213
.
Christopher D. Zahm, Viswa T. Colluru, Sean J. McIlwain, Irene M. Ong & Douglas G. McNeel. (2018) TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells. Cancer Immunology Research 6:11, pages 1364-1374.
Crossref
Crossref
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, Simone Lucchesi, Gabiria Pastore, Jlenia Brunetti, Francesco Santoro, Peter Andersen, Luisa Bracci, Gianni Pozzi & Donata Medaglini. (2018) Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System. Frontiers in Immunology 9.
Crossref
Crossref
María Cristina Pistoresi-Palencia, María Florencia Harman & Sofía Daiana Castell. 2018. Handbook of Immunosenescence. Handbook of Immunosenescence
1
21
.
Jean-Marc Cavaillon & Mervyn SingerDennis M. Klinman & Hidekazu Shirota. 2017. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Inflammation - From Molecular and Cellular Mechanisms to the Clinic
143
174
.
Kaiyu Jiang, Laiping Wong, Ashley D. Sawle, M. Barton Frank, Yanmin Chen, Carol A. Wallace & James N. Jarvis. (2016) Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritis. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Robert A. Mitchell, Rita Altszuler, Ute Frevert & Elizabeth H. Nardin. (2016) Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity. Scientific Reports 6:1.
Crossref
Crossref
Kui Wang, Forrest M. Kievit & Miqin Zhang. (2016) Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies. Pharmacological Research 114, pages 56-66.
Crossref
Crossref
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, Gabiria Pastore, Peter Andersen, Gianni Pozzi & Donata Medaglini. (2016) Modulation of Primary Immune Response by Different Vaccine Adjuvants. Frontiers in Immunology 7.
Crossref
Crossref
Yushan Ren, Yuan-Qin Min, Min Liu, Lianli Chi, Ping Zhao & Xiao-Lian Zhang. (2016) N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:8, pages 1764-1775.
Crossref
Crossref
A.N. Aljurayyan, R. Sharma, N. Upile, H. Beer, C. Vaughan, C. Xie, P. Achar, M.S. Ahmed, P.S. McNamara, S.B. Gordon & Q. Zhang. (2016) A critical role of T follicular helper cells in human mucosal anti-influenza response that can be enhanced by immunological adjuvant CpG-DNA. Antiviral Research 132, pages 122-130.
Crossref
Crossref
Gabriela V. Ullio Gamboa, Luciano A. Benedini, Pablo C. Schulz & Daniel A. Allemandi. (2016) Phase Behavior of Ascorbyl Palmitate Coagels Loaded with Oligonucleotides as a New Carrier for Vaccine Adjuvants. Journal of Surfactants and Detergents 19:4, pages 747-757.
Crossref
Crossref
Z Fang, Q Xu, JQ Wu, SJ Lu, YY Wang & H Fang. (2016) A recombinant plasmid of composite cysteine proteinase inhibitor/ glyceraldehyde-3-phosphate dehydrogenase gene of periodic Brugia malayi functions on DNA immunity in the host. Indian Journal of Medical Microbiology 34:2, pages 146-152.
Crossref
Crossref
Saidou Balam, Ali Jafarshad, Catherine Servis, Geraldine Frank, Steve Reed, Richard Pink, Pierre Druilhe, François Spertini & Giampietro Corradin. (2016) Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice. Vaccine 34:13, pages 1566-1574.
Crossref
Crossref
Gokul Swaminathan, Elizabeth A. Thoryk, Kara S. Cox, Steven Meschino, Sheri A. Dubey, Kalpit A. Vora, Robert Celano, Marian Gindy, Danilo R. Casimiro & Andrew J. Bett. (2016) A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens. Vaccine 34:1, pages 110-119.
Crossref
Crossref
Xiaomin Kang, Xiaoxin Zhang & Aimin Zhao. (2016) Macrophage depletion and TNF-α inhibition prevent resorption in CBA/J × DBA/2 model of CpG-induced abortion. Biochemical and Biophysical Research Communications 469:3, pages 704-710.
Crossref
Crossref
Laura E. Ruff, Dina Uzri, Jessie-F. Fecteau, Mehmet Hikmet Ucisik & Bradley T. Messmer. 2016. Rolling Circle Amplification (RCA). Rolling Circle Amplification (RCA)
161
168
.
Annalisa Ciabattini, Gennaro Prota, Dennis Christensen, Peter Andersen, Gianni Pozzi & Donata Medaglini. (2015) Characterization of the Antigen-Specific CD4+ T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes. Frontiers in Immunology 6.
Crossref
Crossref
Duarte Miguel F. Prazeres & Gabriel A. Monteiro. 2015. Plasmids. Plasmids
669
688
.
Mayda Gursel & Dennis M. Klinman. 2015. Mucosal Immunology. Mucosal Immunology
1201
1209
.
Duarte Miguel F. Prazeres & Gabriel A. Monteiro. (2014) Plasmid Biopharmaceuticals. Microbiology Spectrum 2:6.
Crossref
Crossref
Elke Bergmann-Leitner & Wolfgang Leitner. (2014) Adjuvants in the Driver’s Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators. Vaccines 2:2, pages 252-296.
Crossref
Crossref
Harshal Zope, Christophe Barnier Quer, Paul H. H. Bomans, Nico A. J. M. Sommerdijk, Alexander Kros & Wim Jiskoot. (2013) Peptide Amphiphile Nanoparticles Enhance the Immune Response Against a CpG‐Adjuvanted Influenza Antigen. Advanced Healthcare Materials 3:3, pages 343-348.
Crossref
Crossref
Janine L. Brown. 2014. Reproductive Sciences in Animal Conservation. Reproductive Sciences in Animal Conservation
135
169
.
S. Hu, H. Chen, J. Ma, Q. Chen, H. Deng, F. Gong, H. Huang & C. Shi. (2013)
CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against
Mycobacterium tuberculosis
infection
. Journal of Applied Microbiology 115:5, pages 1203-1211.
Crossref
Crossref
Monika Polewicz, Aleksandra Gracia, Srinivas Garlapati, Jill van Kessel, Stacy Strom, Scott A. Halperin, Robert E.W. Hancock, Andrew A. Potter, Lorne A. Babiuk & Volker Gerdts. (2013) Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. Vaccine 31:31, pages 3148-3155.
Crossref
Crossref
Gaëlle Vacher, Matthias D. Kaeser, Christian Moser, Robert Gurny & Gerrit Borchard. (2013) Recent Advances in Mucosal Immunization Using Virus-like Particles. Molecular Pharmaceutics 10:5, pages 1596-1609.
Crossref
Crossref
Yun Sun, Xiaoli Qin, Bin Shan, Wenjing Wang, Qinling Zhu, Surendra Sharma, Ji Wu & Yi Lin. (2013) Differential effects of the CpG-toll-like receptor 9 axis on pregnancy outcome in nonobese diabetic mice and wild-type controls. Fertility and Sterility 99:6, pages 1759-1767.e4.
Crossref
Crossref
Luis A. Brito, Padma Malyala & Derek T. O’Hagan. (2013) Vaccine adjuvant formulations: A pharmaceutical perspective. Seminars in Immunology 25:2, pages 130-145.
Crossref
Crossref
Neha Kamran, Yoshimi Takai, Jun Miyoshi, Subhra K. Biswas, Justin S. B. Wong & Stephan Gasser. (2013) Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells. PLoS ONE 8:1, pages e54406.
Crossref
Crossref
Maria Luisa Visciano, Maria Tagliamonte, Maria Lina Tornesello, Franco M Buonaguro & Luigi Buonaguro. (2012) Effects of adjuvants on IgG subclasses elicited by virus-like Particles. Journal of Translational Medicine 10:1.
Crossref
Crossref
Romina P Ranocchia, Carolina V Gorlino, María I Crespo, María F Harman, Miriam V Liscovsky, Gabriel Morón, Belkys A Maletto & María C Pistoresi‐Palencia. (2011)
Arginase‐dependent suppression by CpG‐ODN plus IFA‐induced splenic myeloid CD11b
+
Gr1
+
cells
. Immunology & Cell Biology 90:7, pages 710-721.
Crossref
Crossref
Z Fang, H Tong, S Zhang, H Fang, S Lu & B Xu. (2012) Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity. Indian Journal of Medical Microbiology 30:2, pages 193-197.
Crossref
Crossref
Ayman Al-Mariri, Nermeen Haj Mahmoud & Razan Hammoud. (2012) Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice. Biologicals 40:2, pages 140-145.
Crossref
Crossref
Niall McMullan. 2012. Molecular and Cellular Therapeutics. Molecular and Cellular Therapeutics
286
303
.
Fabien Rebeaud & Martin Bachmann. 2012. Innovation in Vaccinology. Innovation in Vaccinology
87
122
.
Rino Rappuoli & Ennio De GregorioGan ZhaoDebra TrossDennis M Klinman. 2011. Novel Immunologic Adjuvants. Novel Immunologic Adjuvants
92
102
.
Ren ZhuMaryline Mancini-Bourgine, Xiao Ming Zhang, Florence Bayard, Qiang Deng & Marie-Louise Michel. (2011) Plasmid Vector-Linked Maturation of Natural Killer (NK) Cells Is Coupled to Antigen-Dependent NK Cell Activation during DNA-Based Immunization in Mice. Journal of Virology 85:19, pages 10201-10212.
Crossref
Crossref
Dianna Rynkiewicz, Melinda Rathkopf, Iain Sim, A. Thomas Waytes, Robert J. Hopkins, Lallan Giri, Deborah DeMuria, Janet Ransom, James Quinn, Gary S. Nabors & Carl J. Nielsen. (2011) Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers. Vaccine 29:37, pages 6313-6320.
Crossref
Crossref
Matthew E. Cohen, Yuhong Xiao, Roselyn J. Eisenberg, Gary H. Cohen & Stuart N. Isaacs. (2011) Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors. PLoS ONE 6:6, pages e20597.
Crossref
Crossref
Jane E. Libbey & Robert S. Fujinami. (2011) Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine 29:17, pages 3356-3362.
Crossref
Crossref
Folkert Steinhagen, Takeshi Kinjo, Christian Bode & Dennis M. Klinman. (2011) TLR-based immune adjuvants. Vaccine 29:17, pages 3341-3355.
Crossref
Crossref
Annina M. Hafner, Blaise Corthésy, Marcus Textor & Hans P. Merkle. (2011) Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling. Biomaterials 32:10, pages 2651-2661.
Crossref
Crossref
Aleksandra Gracia, Monika Polewicz, Scott A. Halperin, Robert E.W. Hancock, Andrew A. Potter, Lorne A. Babiuk & Volker Gerdts. (2011) Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations. Vaccine 29:8, pages 1595-1604.
Crossref
Crossref
Ivan MikulaJr.Jr. & Ivan MikulaSr.Sr.. (2011) Characterization of ovine Toll-like receptor 9 protein coding region, comparative analysis, detection of mutations and maedi visna infection. Developmental & Comparative Immunology 35:2, pages 182-192.
Crossref
Crossref
Dodi Safari, Huberta A. Th. Dekker, Ger Rijkers & Harm Snippe. (2011) Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates. Vaccine 29:4, pages 849-854.
Crossref
Crossref
Tao Jiang, Hui Zhao, Xiao-Feng Li, Yong-Qiang Deng, Juan Liu, Li-Juan Xu, Jian-Feng Han, Rui-Yuan Cao, E-De Qin & Cheng-Feng Qin. (2011) CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model. Antiviral Research 89:1, pages 124-126.
Crossref
Crossref
Hideyuki Nakashima, Toshio Fujisawa, Syed R Husain & Raj K Puri. (2010) Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models. Journal of Translational Medicine 8:1.
Crossref
Crossref
Elke Saile & Conrad P. Quinn. 2010. Bacillus anthracis and Anthrax. Bacillus anthracis and Anthrax
269
293
.
Mitali Sarkar-Tyson & Richard W. Titball. (2010) Progress toward development of vaccines against melioidosis: A review. Clinical Therapeutics 32:8, pages 1437-1445.
Crossref
Crossref
. (2010) Scientific Opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feed. EFSA Journal 8:7, pages 1700.
Crossref
Crossref
Yu. A. Popov & N. I. Mikshis. (2010) Genetic (DNA) Vaccines. Problems of Particularly Dangerous Infections:3(105), pages 20-24.
Crossref
Crossref
Zvi RappoportAndrea Porcheddu & Giampaolo Giacomelli. 2010. Patai's Chemistry of Functional Groups. Patai's Chemistry of Functional Groups.
Jason M. Steiner, Marta Sartor, Ana B. Sanchez, Davorka Messmer, Anna Freed, Sadik Esener & Bradley T. Messmer. (2010) DeNAno: Selectable deoxyribonucleic acid nanoparticle libraries. Journal of Biotechnology 145:4, pages 330-333.
Crossref
Crossref
Jianfei Qian, Sungyoul Hong, Siqing Wang, Liang Zhang, Luhong Sun, Michael Wang, Jing Yang, Larry W. Kwak, Jian Hou & Qing Yi. (2009) Myeloma cell line–derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma. Blood 114:18, pages 3880-3889.
Crossref
Crossref
Hongzhuan Wu, Vida A. Dennis, Shreekumar R. Pillai & Shree R. Singh. (2009) RSV fusion (F) protein DNA vaccine provides partial protection against viral infection. Virus Research 145:1, pages 39-47.
Crossref
Crossref
Michael J. Heffernan & Niren Murthy. (2009) Disulfide-Crosslinked Polyion Micelles for Delivery of Protein Therapeutics. Annals of Biomedical Engineering 37:10, pages 1993-2002.
Crossref
Crossref
Jessica E. Thaxton, Roberto Romero & Surendra Sharma. (2009) TLR9 Activation Coupled to IL-10 Deficiency Induces Adverse Pregnancy Outcomes. The Journal of Immunology 183:2, pages 1144-1154.
Crossref
Crossref
Kent A. Smith, Victor L. Tam, Raymond M. Wong, Robb R. Pagarigan, Brenna L. Meisenburg, Diljeet K. Joea, Xiping Liu, Christiana Sanders, David Diamond, Thomas M. Kündig, Zhiyong Qiu & Adrian Bot. (2009) Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine 27:19, pages 2603-2615.
Crossref
Crossref
Srinivas Garlapati, Marina Facci, Monika Polewicz, Stacy Strom, Lorne A. Babiuk, George Mutwiri, Robert E.W. Hancock, Melissa R. Elliott & Volker Gerdts. (2009) Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Veterinary Immunology and Immunopathology 128:1-3, pages 184-191.
Crossref
Crossref
Dennis M. Klinman & Debra Tross. (2009) A single-dose combination therapy that both prevents and treats anthrax infection. Vaccine 27:12, pages 1811-1815.
Crossref
Crossref
Dennis M. Klinman, Sven Klaschik, Takashi Sato & Debbie Tross. (2009) CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Advanced Drug Delivery Reviews 61:3, pages 248-255.
Crossref
Crossref
Rima Benferhat, Frédéric Martinon, Bernard Krust, Roger Le Grand & Ara G. Hovanessian. (2009) The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope. Molecular Immunology 46:4, pages 705-712.
Crossref
Crossref
Noah W. Palm & Ruslan Medzhitov. (2008) Pattern recognition receptors and control of adaptive immunity. Immunological Reviews 227:1, pages 221-233.
Crossref
Crossref
Sylvie Bertholet, Gregory C. Ireton, Maria Kahn, Jeffrey Guderian, Raodoh Mohamath, Nicole Stride, Elsa M. Laughlin, Susan L. Baldwin, Thomas S. Vedvick, Rhea N. Coler & Steven G. Reed. (2008)
Identification of Human T Cell Antigens for the Development of Vaccines against
Mycobacterium tuberculosis
. The Journal of Immunology 181:11, pages 7948-7957.
Crossref
Crossref
Amit Lahiri, Priyanka Das & Dipshikha Chakravortty. (2008) Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond. Vaccine 26:52, pages 6777-6783.
Crossref
Crossref
Debra Tross & Dennis M. Klinman. (2008) Effect of CpG Oligonucleotides on Vaccine-Induced B Cell Memory. The Journal of Immunology 181:8, pages 5785-5790.
Crossref
Crossref
Sunita Kanswal, Nora Katsenelson, Angamuthu Selvapandiyan, Richard J. Bram & Mustafa Akkoyunlu. (2008) Deficient TACI Expression on B Lymphocytes of Newborn Mice Leads to Defective Ig Secretion in Response to BAFF or APRIL. The Journal of Immunology 181:2, pages 976-990.
Crossref
Crossref
Anju Bansal, Bethany Jackson, Kim West, Shixia Wang, Shan Lu, Jeffrey S. Kennedy & Paul A. Goepfert. (2008) Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of Administration. Journal of Virology 82:13, pages 6458-6469.
Crossref
Crossref
Jean-Pierre Y. Scheerlinck, Kenneth J. Snibson, Vernon M. Bowles & Philip Sutton. (2008) Biomedical applications of sheep models: from asthma to vaccines. Trends in Biotechnology 26:5, pages 259-266.
Crossref
Crossref
Laurent Malherbe, Linda Mark, Nicolas Fazilleau, Louise J. McHeyzer-Williams & Michael G. McHeyzer-Williams. (2008) Vaccine Adjuvants Alter TCR-Based Selection Thresholds. Immunity 28:5, pages 698-709.
Crossref
Crossref
Koon-Guan Lee, Shengli Xu, Ee-Tsin Wong, Vinay Tergaonkar & Kong-Peng Lam. (2008) Bruton's Tyrosine Kinase Separately Regulates NFκB p65RelA Activation and Cytokine Interleukin (IL)-10/IL-12 Production in TLR9-stimulated B Cells. Journal of Biological Chemistry 283:17, pages 11189-11198.
Crossref
Crossref
Zhiyong Qiu & Kent A. Smith. 2008. Cancer Vaccines: Challenges and Opportunities in Translation. Cancer Vaccines: Challenges and Opportunities in Translation
131
150
.
Seng Gee Lim. (2008) Heplisav™: a new hepatitis B vaccine. Future Virology 3:2, pages 109-117.
Crossref
Crossref
Anna Luganini, Patrizia Caposio, Santo Landolfo & Giorgio Gribaudo. (2008) Phosphorothioate-Modified Oligodeoxynucleotides Inhibit Human Cytomegalovirus Replication by Blocking Virus Entry. Antimicrobial Agents and Chemotherapy 52:3, pages 1111-1120.
Crossref
Crossref
M J Grimshaw, K Papazisis, G Picco, H Bohnenkamp, T Noll, J Taylor-Papadimitriou & J Burchell. (2008) Immunisation with ‘naïve’ syngeneic dendritic cells protects mice from tumour challenge. British Journal of Cancer 98:4, pages 784-791.
Crossref
Crossref
Jason Rice, Christian H. Ottensmeier & Freda K. Stevenson. (2008) DNA vaccines: precision tools for activating effective immunity against cancer. Nature Reviews Cancer 8:2, pages 108-120.
Crossref
Crossref
Xiuping Liu, Lee M. Wetzler & Paola Massari. (2008) The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant. Vaccine 26:6, pages 786-796.
Crossref
Crossref
Bénédicte Danis, Thaddeus C. George, Stanislas Goriely, Binita Dutta, Joëlle Renneson, Laurent Gatto, Patricia Fitzgerald‐Bocarsly, Arnaud Marchant, Michel Goldman, Fabienne Willems & Dominique De Wit. (2008) Interferon regulatory factor 7‐mediated responses are defective in cord blood plasmacytoid dendritic cells. European Journal of Immunology 38:2, pages 507-517.
Crossref
Crossref
Young Woo HanAbi G. AleyasJunu A. GeorgeSeon Ju KimHye Kyung KimHyun A YoonDong Jin YooSeong Ho KangKoanhoi KimSeong Kug Eo. (2008) Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus. Experimental and Molecular Medicine 40:6, pages 583.
Crossref
Crossref
Frederick R. Vogel & Stanley L. Hem. 2008. Vaccines. Vaccines
59
71
.
Saumyabrata Mazumder, Rajesh Ravindran, Antara Banerjee & Nahid Ali. (2007) Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice. Vaccine 25:52, pages 8771-8781.
Crossref
Crossref
Robert F. Ashman & Petar Lenert. (2007) Structural requirements and applications of inhibitory oligodeoxyribonucleotides. Immunologic Research 39:1-3, pages 4-14.
Crossref
Crossref
Hong-Duck Kim, Jing-Ji Jin, J. Adam Maxwell & Ken-ichiro Fukuchi. (2007) Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease. Immunology Letters 112:1, pages 30-38.
Crossref
Crossref
Grethe S. Foss & Sissel Rogne. (2007) When gene medication is also genetic modification – Regulating DNA treatment. Vaccine 25:30, pages 5613-5618.
Crossref
Crossref
Valentin V. Vlassov, Pavel P. Laktionov & Elena Y. Rykova. (2007) Extracellular nucleic acids. BioEssays 29:7, pages 654-667.
Crossref
Crossref
Derek T O'Hagan. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Nicolas Spinelli, Om Prakash Edupuganti, Eric Defrancq & Pascal Dumy. (2006) New Solid Support for the Synthesis of 3‘-Oligonucleotide Conjugates through Glyoxylic Oxime Bond Formation. Organic Letters 9:2, pages 219-222.
Crossref
Crossref
Eric Soler & Louis-Marie Houdebine. 2007.
65
94
.
David A. Hokey & David B. Weiner. (2006) DNA vaccines for HIV: challenges and opportunities. Springer Seminars in Immunopathology 28:3, pages 267-279.
Crossref
Crossref